According to Fox News, former President Donald Trump has signed an executive order promoting his 'Made in America' agenda by incentivizing prescription drug manufacturing within the United States. This policy is expected to redirect supply chains and could increase investments in domestic pharmaceutical infrastructure. Traders should note that increased US pharmaceutical activity may lead to higher demand for blockchain-based supply chain solutions and tokenized assets, with potential positive impacts on healthcare-focused cryptocurrencies and related DeFi projects. Source: Fox News, May 6, 2025.